Photon's structural advantage is that it owns the end-to-end prescription path rather than competing as a pure routing layer or a single-channel pharmacy. The combined prescriber-side infrastructure, pharmacy network, and consumer marketplace lets Photon deliver real-time price and availability transparency at the moment a prescription is written — a position that legacy e-prescribing networks (Surescripts), PBM-owned mail-order pharmacies, and pure direct-to-consumer pharmacies cannot occupy without restructuring.
Distribution is reinforced by enterprise integrations: Photon powers prescription experiences for Amazon Pharmacy, Sesame, Found, NormanMD, Measured, Athena Health, Blueberry Pediatrics, and Cost Plus, which surfaces Photon as the de-facto pharmacy layer for new digital health builders rather than a swap-in vendor for incumbents. A 2026 Series A led by Healthier Capital with participation from Notation, Flare Capital, and Evidenced extends this position by funding deeper marketplace coverage and prescriber tooling.
